Wan‐Fen Li

A novel selective AKR1C3-activated prodrug AST-3424/OBI-3424 exhibits broad anti-tumor activity.

Jianxin Duan, D. Jung, Tianyang Qi, 2021, American journal of cancer research.

T cell epitope selection: dominance may be determined by both affinity for major histocompatibility complex and stoichiometry of epitope

M. Lai, C. Pan, W. F. Li, 1992, European journal of immunology.

Preclinical Studies of OBI-999: A Novel Globo H–Targeting Antibody–Drug Conjugate

M. Lai, Hui-Wen Chang, Teng-Yi Huang, 2021, Molecular Cancer Therapeutics.

Immunogenicity of a spike protein subunit-based COVID-19 vaccine with broad protection against various SARS-CoV-2 variants in animal studies

M. Lai, J. Lai, Hsin-Yi Tung, 2023, PloS one.

Modulation of restricted class II T cell responses by peptides derived from self class II molecule

M. Gefter, M. Lai, Wan‐Fen Li, 1992, European journal of immunology.